Загрузка...
Megestrol acetate for cachexia–anorexia syndrome. A systematic review
In 1993, megestrol acetate (MA) was approved by the US Food and Drug Administration for the treatment of anorexia, cachexia, or unexplained weight loss in patients with acquired immunodeficiency syndrome. The mechanism by which MA increases appetite is unknown, and its effectiveness for anorexia and...
Сохранить в:
| Опубликовано в: : | J Cachexia Sarcopenia Muscle |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5989756/ https://ncbi.nlm.nih.gov/pubmed/29542279 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcsm.12292 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|